RBF Capital’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-600,000
| Closed | -$1.89M | – | 423 |
|
|
2020
Q3 | $1.89M | Hold |
600,000
| – | – | 0.19% | 114 |
|
|
2020
Q2 | $1.75M | Hold |
600,000
| – | – | 0.19% | 112 |
|
|
2020
Q1 | $1.69M | Hold |
600,000
| – | – | 0.22% | 102 |
|
|
2019
Q4 | $1.95M | Buy |
600,000
+30,677
| +5% | +$99.5K | 0.19% | 112 |
|
|
2019
Q3 | $1.23M | Hold |
569,323
| – | – | 0.14% | 137 |
|
|
2019
Q2 | $1.79M | Hold |
569,323
| – | – | 0.18% | 108 |
|
|
2019
Q1 | $2.12M | Sell |
569,323
-23,090
| -4% | -$85.9K | 0.25% | 83 |
|
|
2018
Q4 | $1.72M | Buy |
592,413
+419,323
| +242% | +$1.22M | 0.22% | 89 |
|
|
2018
Q3 | $455K | Hold |
173,090
| – | – | 0.05% | 246 |
|
|
2018
Q2 | $407K | Hold |
173,090
| – | – | 0.05% | 249 |
|
|
2018
Q1 | $508K | Hold |
173,090
| – | – | 0.06% | 221 |
|
|
2017
Q4 | $474K | Sell |
173,090
-4,355
| -2% | -$11.9K | 0.05% | 227 |
|
|
2017
Q3 | $602K | Hold |
177,445
| – | – | 0.08% | 187 |
|
|
2017
Q2 | $438K | Hold |
177,445
| – | – | 0.06% | 216 |
|
|
2017
Q1 | $403K | Sell |
177,445
-73,976
| -29% | -$168K | 0.06% | 227 |
|
|
2016
Q4 | $540K | Sell |
251,421
-22,555
| -8% | -$48.4K | 0.08% | 193 |
|
|
2016
Q3 | $918K | Hold |
273,976
| – | – | 0.16% | 127 |
|
|
2016
Q2 | $860K | Hold |
273,976
| – | – | 0.17% | 129 |
|
|
2016
Q1 | $912K | Hold |
273,976
| – | – | 0.17% | 136 |
|
|
2015
Q4 | $970K | Buy |
+273,976
| New | +$970K | 0.18% | 131 |
|